Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Can-Fite Biopharma Ltd
(NY:
CANF
)
2.380
USD
-0.030 (-1.24%)
Official Closing Price
Updated: 8:00 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Can-Fite Biopharma Ltd
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies
April 05, 2021
Can-Fite: Cannabis Compound Inhibits Liver Cancer Growth in Preclinical Studies
From
Business Wire News Releases
Can-Fite: Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million
March 30, 2021
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...
From
Business Wire News Releases
Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
March 25, 2021
Can-Fite Reports 2020 Financial Results & Provides Clinical Development Update
From
Business Wire News Releases
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
March 19, 2021
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
From
Business Wire News Releases
Thinking about buying stock in Neos Therapeutics, Oriental Culture, Sino-Global Shipping, Bank of America, or Can Fite Biopharma?
March 18, 2021
InvestorsObserver issues critical PriceWatch Alerts for NEOS, OCG, SINO, BAC, and CANF.
From
PR Newswire
Thinking about buying stock in Can Fite Biopharma, Aytu Bioscience, Hall of Fame Resort & Entertainment, Brickell Biotech, or Infinity Pharmaceuticals?
March 18, 2021
InvestorsObserver issues critical PriceWatch Alerts for CANF, AYTU, HOFV, BBI, and INFI.
From
PR Newswire
Can-Fite: Topical Administration of CF602 Fully Recovers Erectile Dysfunction in Diabetic Model
March 18, 2021
Topical Administration of CF602 Fully Recovers Erectile Dysfunction in Diabetic Model. Issued Patents in major markets.
From
Business Wire News Releases
Thinking about buying stock in Can Fite, Zomedica, AMC Entertainment, Savara, or SunLink Health?
March 16, 2021
InvestorsObserver issues critical PriceWatch Alerts for CANF, ZOM, AMC, SVRA, and SSY.
From
PR Newswire
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
March 16, 2021
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
From
Business Wire News Releases
Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
March 05, 2021
Can-Fite Enrolls First Patient in Phase II COVID-19 Study Under FDA Protocol
From
Business Wire News Releases
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp?
February 22, 2021
InvestorsObserver issues critical PriceWatch Alerts for CLSN, CANF, CFMS, CTXR, and VUZI.
From
PR Newswire
New Positive Data from Can-Fite’s Liver Cancer Phase II Clinical Study with Namodenoson
February 22, 2021
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...
From
Business Wire News Releases
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech?
February 12, 2021
InvestorsObserver issues critical PriceWatch Alerts for CANF, CLSN, MARK, PSTV, and SNES.
From
PR Newswire
Can-Fite Announces Inhibition of Liver Fibrosis by Cannabis Compounds in Preclinical Studies
February 01, 2021
Can-Fite Announces Inhibition of Liver Fibrosis by Cannabis Compounds in Preclinical Studies
From
Business Wire News Releases
Can-Fite’s NASH Indication Highlighted in Webinar by KOL Dr. Harrison: “Namodenoson May Have Big Impact on NASH”
January 28, 2021
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...
From
Business Wire News Releases
Can-Fite Announces Publication of Namodenoson Liver Cancer Study in Peer Reviewed Journal—Cancers
January 08, 2021
Can-Fite Announces Publication of Namodenoson Liver Cancer Study in Peer Reviewed Journal—Cancers
From
Business Wire News Releases
Can-Fite Receives Israel Ministry of Health Approval to Conduct Research with Cannabinoids in Cancer, Inflammation and Obesity at the Company Discovery Labs
December 15, 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...
From
Business Wire News Releases
Can-Fite Reports on Progress With Its Namodenoson NASH Program
December 14, 2020
Can-Fite Reports on Progress with its Namodenoson NASH Program
From
Business Wire News Releases
Can-Fite to Present at Benzinga Global Small Cap Conference on December 8, 2020
December 03, 2020
Can-Fite to Present at Benzinga Global Small Cap Conference on December 8, 2020
From
Business Wire News Releases
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
November 30, 2020
Can-Fite Reports Third Quarter 2020 Financial Results & Provides Clinical Update
From
Business Wire News Releases
Can-Fite’s Namodenoson Abstract Selected as ‘Best of The Liver Meeting’ in the NASH Category of the American Association of Liver Diseases (AASLD)
November 24, 2020
Can-Fite’s Namodenoson Abstract Selected as ‘Best of The Liver Meeting ‘ in the NASH Category of the American Association of Liver Diseases (AASLD)
From
Business Wire News Releases
Can-Fite to Conduct Investor Call to Review Q3 Results and Provide Business Update on Monday, November 30, 2020 at 9:15 a.m. ET
November 23, 2020
Can-Fite to Conduct Investor Call to Review Q3 Results and Provide Business Update on Monday, November 30, 2020 at 9:15 a.m. ET
From
Business Wire News Releases
Can-Fite Presented NASH Phase II Namodenoson Data at a Late Breaking Session of the American Association for the Study of Liver Diseases (AASLD) Conference
November 16, 2020
Can-Fite Presented NASH Phase II Namodenoson Data at a Late Breaking Session of AASLD Conference
From
Business Wire News Releases
Can-Fite to Present its NASH Program in Fireside Chat at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020
November 09, 2020
Can-Fite to Present its NASH Program in Fireside Chat at the H.C. Wainwright 6th Annual Israel Conference on November 12, 2020
From
Business Wire News Releases
Thinking about buying stock in OraSure Technologies, AMC Entertainment, Can Fite Biopharma, American Airlines, or Canopy Growth Corp?
October 19, 2020
InvestorsObserver issues critical PriceWatch Alerts for OSUR, AMC, CANF, AAL, and CGC.
From
PR Newswire
Can-Fite to Host Conference Call to Update Shareholders on Positive Interim Results of its Phase III Psoriasis Study on October 15, 2020
October 13, 2020
Can-Fite to Host Conference Call to Update Shareholders on Positive Interim Results of its Phase III Psoriasis Study on October 15, 2020
From
Business Wire News Releases
Can-Fite Announces Positive Phase III Psoriasis Interim Data Analysis
October 06, 2020
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today...
From
Business Wire News Releases
Can-Fite Selected to Deliver Late-Breaking Oral Presentation on Namodenoson’s Treatment of NASH at American Association for the Study of Liver Diseases Conference
September 30, 2020
Can-Fite Selected to Deliver Late-Breaking Presentation on Namodenoson’s Treatment of NASH at American Association for the Study of Liver Diseases
From
Business Wire News Releases
Can-Fite to Participate in Two BioPharma Partnering Conferences
September 22, 2020
Can-Fite to Participate in Two BioPharma Partnering Conferences
From
Business Wire News Releases
Thinking about buying stock in Can Fite Biopharma, Inovio Pharmaceuticals, Penn National Gaming, Delta Air Lines, or Advanced Micro Devices?
September 08, 2020
InvestorsObserver issues critical PriceWatch Alerts for CANF, INO, PENN, DAL, and AMD.
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.